
Remote Patient Monitoring Devices Market Share, Size, Growth and Forecast Report, 2022 to 2030
Healthcare & Life Sciences
PDF,PPT
Reports and Insights
311
June 2022
Recent
Remote Patient Monitoring Devices Market Overview
The report is titled as ‘Remote Patient Monitoring Devices Market: Opportunity Analysis and Future Assessment 2022-2030’. An overview of conceptual frameworks, analytical approaches of the Remote Patient Monitoring Devices market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.
The remote patient monitoring devices market is estimated to reach at a value of US$ 25.1 Bn by the end of 2022 and expected to reach at a value of US$ 93.8 Bn by 2030 with a significant CAGR of 17.9%.
Remote Patient Monitoring Devices Introduction
Remote patient monitoring (RPM) can be perceived as a healthcare delivery approach that employs technology to keep track of patient health outside of a conventional clinical atmosphere. RPM alludes to the specialized technology employed to electronically transfer information between patients and practitioners, and it is just one delivery system within the comprehensive telemedicine industry. Some of the few examples of remote health monitoring devices comprise uninterrupted glucose monitors that alert diabetes patients to take their insulin, whilst enabling their medical practitioner to check upon the disease, digital blood pressure monitors that allow patients to distantly send physicians their blood oxygen levels and blood pressure.
Remote patient monitoring devices strike digital technology in order to transmit communications between providers and patients. Patients keep a check on themselves to gather data about their condition and overall well-being at different points throughout the day, and then further transfer secure data in messages electronically to their technicians or clinicians. Moreover, RPM systems carry an enormous potential for propagating savings by avoiding more costly and severe health outputs from setting down roots. The growing prevalence of chronic ailments among the population is primarily projected to drive the growth of the global remote patient monitoring devices market in the following years.
Remote Patient Monitoring Devices Market Segmentation
The global remote patient monitoring devices market is segmented on the basis of product, application, modality, end use, and region.
By Product
Pressure Monitors
Hemodynamic Monitors
Blood Pressure Monitors
Disposables
Cardiac Monitoring Devices
ECG Devices
Implantable Loop Recorders
Event Monitors
Mobile Cardiac Telemetry Monitors
Temperature Monitor
Fetal and Neonatal Monitoring Devices
Respiratory Rate Monitor
Pulse Oximeters
Spirometers
Capnographs
Peak Flow Meters
Brain Monitoring (EEG)
Specialized Monitors
Anesthesia Monitors
Blood Glucose Monitors
Self-monitoring Blood Glucose Systems
Continuous Glucose Monitoring Systems
Prothrombin Monitors
Multi Parameter Monitors (MPM)
Low-acuity Monitoring Devices
Mid-acuity Monitoring Devices
High-acuity Monitoring Devices
Others
By Modality
Benchtop
Wearable
Invasive
By Application
Cardiovascular Diseases
Diabetes
Sleep Disorder
Weight management and Fitness Monitoring
Bronchitis
Infections
Virus
Dehydration
Hypertension
By End-use
Hospital Based Patients
Ambulatory Patients
Home Healthcare
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Remote Patient Monitoring Devices Market Key Players
Some of the key participating players in global Remote Patient Monitoring Devices market are:
BioTelemetry Inc.
Koninklijke Philips N.V.
Medtronic
GE Healthcare
Cerner Corporation
Siemens Healthineers AG
OMRON Healthcare
Boston Scientific Corporation
Abbott Laboratories
Resideo Life Care Solutions
Vivify Health, Inc.
ALTEN Calsoft Labs
Preventice Solutions
Bio-Beat Technologies
VitalConnect
Welch Allyn
Teladoc Health Inc.
Dexcom Inc.
iRhythm Technologies, Inc.
VivaLNK Inc.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product developments and launches
Current product compliance
Reimbursement
Concerns for use of Remote Patient Monitoring Devices
Advantages of Remote Patient Monitoring Devices
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the market.
Frequently Asked Question
What is the projected market size & Compound Annual Growth Rate (CAGR) of the remote patient monitoring devices market?
The remote patient monitoring devices market is estimated to reach at a value of US$ 25.1 Bn by the end of 2022 and expected to reach at a value of US$ 93.8 Bn by 2030 with a significant CAGR of 17.9%.
Which base year is used in the remote patient monitoring devices market report?
The base year for the report is 2022 in remote patient monitoring devices market.
What segments are covered in remote patient monitoring devices market report?
The global remote patient monitoring devices market is segmented on the basis of product, application, modality, end use, and region.
What are the key participating players in the remote patient monitoring devices market?
some of the key participating players in the remote patient monitoring devices market globally are BioTelemetry Inc., Koninklijke Philips N.V., Medtronic, GE Healthcare, Cerner Corporation, Siemens Healthineers AG, OMRON Healthcare, Boston Scientific Corporation, Abbott Laboratories, Resideo Life Care Solutions, Vivify Health, Inc., ALTEN Calsoft Labs, Preventice Solutions, Bio-Beat Technologies, VitalConnect, Welch Allyn, Teladoc Health Inc., Dexcom Inc., iRhythm Technologies, Inc., VivaLNK Inc., among others.